Biotechnology is often touted as key for the future for many knowledge based economies. The path to success is long and more so than many other sectors requires a multidisciplinary approach many times incorporating biologists, engineers, doctors, lawyers, financial investors, marketers, and even lobbyists and politicians. With this in mind, we at BIOVAL are creating a new platform to give a voice to each facet needed to create a dynamic sector. And you are reading it right now.
Up to this point, our efforts have remained largely static. This blog will serve as a more informal dynamic medium featuring the latest news, persons of interest, and essential concepts for small biotech. It will incorporate a large number of contributors to take advantage of a wide range of expertise and opinions. The plan is to update weekly, but with some inspiration, blogs will appear more frequently.
While content will be more focused toward Valencian Biotechnology, it is by no means exclusive to this region. The subject matter is universal and our intension is to bring in national and international experts to broaden both appeal and vision. We welcome external collaborations, feel free to email us with a bit of information about yourself and your idea at email@example.com. Furthermore, take advantage of the comments section below. We will be around to keep the discussion professional and lively.
For the first bit of news, the Expansion covered a report from ASCRI, the Spanish Venture Capitalist Association, detailing an increase in investment in the Valencian Community for the first quarter of 2010 (LINK). A total of 158.7 million euros were invested during the period, substantially more than the 101.4 million from the same period in 2009. However, even more interesting is the quote attributed to Maite Ballester, president of ASCRI, who sees opportunity in sectors based on innovation, specifically naming Biotechnology.
The importance of venture capital in biotechnology cannot be overstated, especially when we consider the national and international financial markets. This problem has been a main concern of BIOVAL over the past year and a number of initiatives have been designed to improve the situation by working with private region private investment companies and creating attractive investment opportunities. While this news and BIOVAL’s actions represent important advances, there is much work to be done from all parties involved. But we can save this for a future entry.